In terms of market performance, Mineralys Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $18.38 on 03/19/25, and the lowest value was recorded at $8.24 on 02/25/25.
52-week price history of MLYS Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Mineralys Therapeutics Inc’s current trading price is -27.37% away from its 52-week high, while its distance from the 52-week low is 61.99%. The stock’s price range during this period has spanned from $8.24 to $18.38. In the Healthcare sector, the Mineralys Therapeutics Inc’s shares surpassed a trading volume of approximately 0.38 million for the day, which was noticeably lower compared to the average daily volume of 9.1.09 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Mineralys Therapeutics Inc (MLYS) has experienced a quarterly rise of 40.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 866.10M and boasts a workforce of 51 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.00, with a change in price of +0.75. Similarly, Mineralys Therapeutics Inc recorded 756,928 in trading volume during the last 100 days, posting a change of +5.95%.
Examining MLYS’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for MLYS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MLYS Stock Stochastic Average
Today, Mineralys Therapeutics Inc’s raw stochastic average for the past 50 days stands at 50.39%, indicating a rise from the raw stochastic average of the last 20 days, which was 42.11%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 43.24% and 42.84% respectively.
MLYS Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 8.45%. However, over the past six months, we’ve seen a stronger performance of -2.55%. The price of MLYS leaped by -20.30% over the last 30 days. And in the last five days, it has surged by 9.52%.
